Human recombinant relaxin reduces heart injury and improves ventricular performance in a swine model of acute myocardial infarction. [electronic resource]
- Annals of the New York Academy of Sciences May 2005
- 431-3 p. digital
Publication Type: Journal Article
0077-8923
10.1196/annals.1282.064 doi
Animals Coronary Vessels--drug effects Disease Models, Animal Heart Ventricles--drug effects Humans Myocardial Infarction--drug therapy Recombinant Proteins--therapeutic use Relaxin--therapeutic use Swine Ventricular Function